Intelligencia Raises $12M To Reduce The Risk Of Clinical Research, Improve R&D Productivity, And Accelerate Scientific Breakthroughs
NEW YORK & ATHENS, Greece & BASEL, Switzerland–(BUSINESS WIRE)–Intelligencia, whose AI-driven software platform enables pharmaceutical and biotechnology companies to revolutionize the drug development process and reduce risk, has raised $12M…